Incyte stock forecast: up to 73.31 USD INCY stock price prognosis

STOCK

Forecast for Fri 26 May 2023 price 76.01

Incyte stock price forecast for further price development up to 4.27% (time horizon: 1 day) and price target of 73.31 USD. Positive news sentiment. Short-term (time horizon: 2 weeks) Incyte share price prediction for 2023-05-26 with daily closed price projections

Key Facts

Symbol INCY 

ISIN US45337C1027 

CUSIP 45337C102

Currency USD

Category Services-Commercial Physical & Biological Research

Forecast price change %

News sentiment (1.00)

News <--> Close correlation for next day influence (0.13)

Finance numbers

Revenue 2,702,913,000.0

Earnings per share 2.21

twitter facebook

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

JAKAFI is the most advanced compound in our JAK program. It is an oral JAK1 and JAK2 inhibitor. Myelofibrosis is a rare, life-threatening condition. We estimate there are between 16,000 and 18,500 patients with MF in the United States. COMFORT-I also demonstrated improvements in symptoms. The median duration of response (mDOR) was 21.7 months. It is often diagnosed late (stages III and IV) and the prognosis is poor. Clinical development of ruxolitinib in GVHD conducted in collaboration with Novartis.2. Development collaboration with Cellenkos, Inc.3. retifanlimab licensed from MacroGenics. Similar requirements exist within foreign agencies as well. Similar risks apply to our supply of MONJUVI under our collaboration with MorphoSys. We sell JAKAFI primarily to specialty pharmacies and wholesalers. We depend heavily on the success of our most advanced drug candidates. A number of our collaborations involve the manufacture of antibodies. would affect potential future royalty and milestone and contract revenue.

Summerized Form 10-K with GPT-2 https://www.sec.gov/Archives/edgar/data/879169/000155837021000825/0001558370-21-000825.txt
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 47.74/100
    • Historical view, profit is growing.
    • Company revenue is not growing faster compared with the industry.
    • Stock price is under book price value.

Institutional ownership list is based on filling form information

Fund ownership list is based on filling form information

Fund name Date Amount Profile
SPDR INDEX SHARES FUNDS 2022-12-31 1512 Long
SPDR SERIES TRUST 2022-12-31 14963 Long
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC 2022-12-31 768 Long
SPDR INDEX SHARES FUNDS 2022-12-31 565 Long
SPDR SERIES TRUST 2022-12-31 945965 Long

Insider trading for Incyte

CIK Name Date Action T-Test 1day T-Test 7day T-Test 14day T-Test 30day
1615842 Flannelly Barry P 2022-07-07 SALE Accept Reject Accept Accept
1736295 Pasquale Maria E 2023-01-31 SALE Accept Accept Accept Accept
1670000 Iyengar Vijay K 2023-01-26 SALE Accept Reject Reject Reject
1673776 Stein Steven H 2023-01-04 SALE Accept Accept Reject Reject
1760682 Dhanak Dashyant 2023-01-26 SALE Accept Accept Accept Accept
1912317 Tray Thomas 2022-12-19 SALE Accept Accept Accept Accept
Assets / Liabilities

Bollinger Bollinger Bands for Incyte can provide the information where the market is moving based on price information.

Incyte Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

Converting prices to returns Incyte.

On-Balance Volume information for Incyte. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for Incyte. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for Incyte. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for Incyte. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for Incyte. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for Incyte. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for Incyte. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

52W High 52W Low Market Cap

Similar shares

Trend:
chart
CYCLACEL PHARMACEUTICALS INC

Trend:
chart
VACCINEX

Trend:
chart
NANOVIRICIDES INC

Trend:
chart
ELOXX PHARMACEUTICALS INC

Incyte on Nasdaq

Incyte on finviz

Figure below show the stock predictions.
Date Closing price Prediction was updated
2023-04-27 73.31 2023-03-31 06:22
2023-04-28 73.43 2023-03-31 06:22
2023-05-01 73.56 2023-03-31 06:22
2023-05-02 73.65 2023-03-31 06:22
2023-05-05 74.09 2023-03-31 06:22
2023-05-08 74.26 2023-03-31 06:22
2023-05-09 74.43 2023-03-31 06:22
2023-05-03 73.80 2023-03-31 06:22
2023-05-10 74.59 2023-03-31 06:22
2023-05-11 74.71 2023-03-31 06:22
2023-05-04 73.92 2023-03-31 06:22
2023-05-12 74.83 2023-03-31 06:22
2023-05-15 74.94 2023-03-31 06:22
2023-05-16 75.06 2023-03-31 06:22
2023-05-17 75.18 2023-03-31 06:22
2023-05-18 75.31 2023-03-31 06:22
2023-05-19 75.44 2023-03-31 06:22
2023-05-25 75.91 2023-03-31 06:22
2023-05-23 75.70 2023-03-31 06:22
2023-05-22 75.57 2023-03-31 06:22
2023-05-24 75.80 2023-03-31 06:22
2023-05-26 76.01 2023-03-31 06:22
2023-04-03 71.15 2023-03-31 06:22
2023-04-04 71.23 2023-03-31 06:22
2023-04-05 70.81 2023-03-31 06:22
2023-04-07 70.91 2023-03-31 06:22
2023-04-06 71.03 2023-03-31 06:22
2023-04-10 71.10 2023-03-31 06:22
2023-04-11 71.27 2023-03-31 06:22
2023-04-12 71.54 2023-03-31 06:22
2023-04-13 71.94 2023-03-31 06:22
2023-04-14 72.04 2023-03-31 06:22
2023-04-17 72.21 2023-03-31 06:22
2023-04-18 72.26 2023-03-31 06:22
2023-04-19 72.29 2023-03-31 06:22
2023-04-20 72.39 2023-03-31 06:22
2023-04-21 72.48 2023-03-31 06:22
2023-04-24 72.73 2023-03-31 06:22
2023-04-25 72.90 2023-03-31 06:22
2023-04-26 73.14 2023-03-31 06:22

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.